Jason C Long

Title: Innovations by Jason C Long

Introduction

Jason C Long is an accomplished inventor based in Newbury Park, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel peptides and inhibitors. With a total of two patents to his name, Long's work addresses critical health issues, including pain management and headache disorders.

Latest Patents

Long's latest patents include innovative solutions such as peptide PAC1 antagonists. These novel peptides bind to human PAC1 and serve as antagonists, proving useful in treating and preventing various PAC1-related disorders, including acute migraine. Additionally, he has developed potent and selective inhibitors of Nav1.7. This composition comprises an isolated polypeptide that acts as a peripherally-restricted Na1.7 inhibitor. The patent also discloses methods for treating or preventing pain, showcasing the potential impact of his work on pain management therapies.

Career Highlights

Long is currently associated with Amgen Inc., a leading biotechnology company known for its focus on innovative therapies. His role at Amgen allows him to leverage his expertise in developing groundbreaking treatments that can significantly improve patient outcomes.

Collaborations

Throughout his career, Long has collaborated with notable colleagues, including Leslie Phillip Miranda and Irwin Chen. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jason C Long's contributions to the field of pharmaceuticals through his innovative patents highlight his commitment to addressing significant health challenges. His work continues to pave the way for advancements in pain management and treatment options for headache disorders.